Cargando…
Development of the Cu/ZIF-8 MOF Acid-Sensitive Nanocatalytic Platform Capable of Chemo/Chemodynamic Therapy with Improved Anti-Tumor Efficacy
[Image: see text] Recently, the combination of chemotherapy and chemodynamic therapy (CDT) has become a desirable strategy in the treatment of cancer. However, a satisfactory therapeutic outcome is often difficult to achieve due to the deficiency of endogenous H(2)O(2) and O(2) in the tumor microenv...
Autores principales: | Liang, Jie, Zhang, Weiwei, Wang, Jun, Li, Wanzhen, Ge, Fei, Jin, Weihao, Tao, Yugui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249029/ https://www.ncbi.nlm.nih.gov/pubmed/37305251 http://dx.doi.org/10.1021/acsomega.3c00269 |
Ejemplares similares
-
Tumor microenvironment-responsive BSA nanocarriers for combined chemo/chemodynamic cancer therapy
por: Zhang, Ruiyi, et al.
Publicado: (2022) -
Self‐Supply of O(2) and H(2)O(2) by a Nanocatalytic Medicine to Enhance Combined Chemo/Chemodynamic Therapy
por: Gao, Shutao, et al.
Publicado: (2019) -
Construction of Novel Nanocomposites (Cu-MOF/GOD@HA) for Chemodynamic Therapy
por: Hao, Ya-Nan, et al.
Publicado: (2021) -
Multi-stimuli responsive Cu-MOFs@Keratin drug delivery system for chemodynamic therapy
por: Du, Jinsong, et al.
Publicado: (2023) -
A self-amplified nanocatalytic system for achieving “1 + 1 + 1 > 3” chemodynamic therapy on triple negative breast cancer
por: Zhou, Lulu, et al.
Publicado: (2021)